Toxic epidermal necrolysis treated with intravenous high-dose immunoglobulins: Our experience

Dermatology

Volumn 203, Issue 1, 2001, Pages 45-49

  Stella, Maurizio ^a,b   Cassano, Pompeo ^a   Bollero, Daniele ^a   Clemente, Alessandra ^a   Giorio, Giusy ^a  

^a Trauma Centre   (Italy)

^b CTO HOSPITAL   (Italy)

Author keywords

Burn centre; Immunoglobulins; Lyell syndrome; Stevens Johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

ALLOPURINOL; ALPRAZOLAM; AMITRIPTYLINE; CIPROFLOXACIN; CISAPRIDE; CLARITHROMYCIN; CLOMIPRAMINE; DEXAMETHASONE; DOXORUBICIN; FAS ANTIBODY; FAS LIGAND; FLUOXETINE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; NORAMIDOPYRINE; PARACETAMOL; PAROXETINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; VINCRISTINE;

ADULT; AGED; APOPTOSIS; ARTICLE; ARTIFICIAL VENTILATION; BODY SURFACE; BURN; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG INDUCED DISEASE; FEMALE; HUMAN; KERATINOCYTE; MALE; NAIL DYSTROPHY; PRIORITY JOURNAL; RESPIRATORY FAILURE; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; TREATMENT OUTCOME; WOUND HEALING;

ADULT; AGED; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0034830802     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051702     Document Type: Article

References (32)

1. Experience with toxic epidermal necrolysis treated in a burn center
2. Toxic epidermal necrolysis
3. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis
4. Epidermal apoptotic cell death in erythema multiforme and Stevens-Johnson syndrome: Contribution of perforin-positive cell infiltration
5. Death receptors in cutaneous biology and disease
6. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
7. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis
8. Drug-induced linear immunoglobulin A bullous disease that clinically mimics toxic epidermal necrolysis
9. Toxic epidermal necrolysis (Lyell syndrome) in 77 elderly patients
10. A 10-year experience with toxic epidermal necrolysis
11. Clinical classification of cases of toxic epidermal necrolysis and erythema multiforme
12. Acute and chronic respiratory complications of toxic epidermal necrolysis
13. Ileal involvement in toxic epidermal necrolysis (Lyell syndrome)
14. Corneal graft after drug-induced toxic epidermal necrolysis (Lyell's disease)
15. Heterotopic ossification as a complication of toxic epidermal necrolysis
16. Toxic epidermal necrolysis and Steven-Johnson syndrome: Does early withdrawal of causative drugs decrease the risk of death?
17. Use of Biobrane in the treatment of toxic epidermal necrolysis
18. Toxic epidermal necrolysis - A retrospective study
19. Toxic epidermal necrolysis treated with cyclosporin and granulocyte colony stimulating factor
20. Treatment of toxic epidermal necrolysis with cyclosporin A
21. Cyclophosphamide in the treatment of toxic epidermal necrolysis
22. Plasma-pheresis as an adjunct treatment in toxic epidermal necrolysis
23. The use of intravenous high-dose immunoglobulins in a case of Stevens-Johnson syndrome
24. Toxic epidermal necrolysis in acquired immunodeficiency syndrome treated with intravenous gammaglobulin
25. Use of intravenous immunoglobulin in the treatment of severe cutaneous drug reactions in patients with AIDS
26. A case of toxic epidermal necrolysis treated with intravenous immunoglobulin
27. Lymphocyte transformation test in toxic epidermal necrolysis (Lyell syndrome)
28. Drug-induced febrile mucocutaneous syndrome
29. The incidence of erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis
30. Incidence of toxic epidermal necrolysis in Italy
31. Toxic epidermal necrolysis (Lyell syndrome): Incidence and drug etiology in France, 1981-1985
32. Epidemiology of drug-induced severe skin reactions